This pathway suppresses aerobic glycolysis and promotes programmed cell death in ESCC cells, suggesting that PDT-mediated ESCC treatment is fundamentally linked to PKM2 inhibition (141, 142). The gene discussed is PKM; the disease is esophageal squamous cell carcinoma.